The new generation of minimally invasive prostheses

Addressing unmet needs in structural heart, vascular and urology diseases.

Therapies for unmet needs

Affluent Medical focuses on breakthrough therapies with a new approach of medical devices.
We develop new generation of minimally invasive prostheses with the aim of mimicking anatomy and restoring native physiology for critical functions.

Kardiozis

Abdominal aortic aneurysm

Kalios

Mitral valve repair

epygon

Mitral valve replacement

artus

Urinary incontinence

Minimally invasive prostheses

News

Affluent Medical postpones planned initial public offering (IPO) on the Euronext Growth Market in Paris

Affluent Medical, a new French medtech player, today announces the postponement of its initial public offering (IPO) to list its shares for

Affluent Medical launches its initial public offering (IPO) on the Euronext Growth Market in Paris

On June 7, 2018, the Autorité des marchés financiers (AMF) approved, under number 18-231, the prospectus relating to the IPO of the shares

Affluent Medical files its “Document de base” as part of its planned initial public offering (IPO) on the Euronext Growth market in Paris

Affluent Medical, a new French medtech player, announces today that it has filed its Document de Base with the Autorité des ma

  • AFFLUENT MEDICAL SA
    5, rue de la Baume
    75008 PARIS

    contact@affluentmedical.com

  • ALIZE RP
    Caroline Carmagnol & Wendy Rigal
    affluentmedical@alizerp.com
    +33 1 44 54 36 66
    +33 6 48 82 18 94

  • ACTIFIN
    Julien Mouret
    affluentmedical@actifin.fr
    +33 1 88 32 11 46